Skip to content
value.today

Tissue Genesis Inc.

Total raised
$14 M
3 rounds on record
Latest round
$8 M
Dec 2011
First round on record
Mar 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Tissue Genesis Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2011$8 MNo. 3$2 to $10 million

Tissue Genesis Inc.: Raise no. 3, Dec 2011

Investors in this round

53 investors had bought by the notice of Jan 4, 2012: 53 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $15 M offered; $8 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Hawaii

People named in the notice

  • Anton C Krucky · Executive Officer, Director
  • Paul C Kosnik · Executive Officer
  • Thomas C Cannon · Executive Officer, Director
  • Jeffrey C Watanabe · Director
  • Michael C Ruley · Director
  • Robert C Hiam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by May Lee, General Counsel. Source: SEC Form D, newest notice filed Jan 4, 2012. Read the notice at the SEC.

equitySEC
Jun 2010$6 MNo. 2$2 to $10 million

Tissue Genesis Inc.: Raise no. 2, Jun 2010

Investors in this round

51 investors had bought by the notice of Jul 11, 2011: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $15 M offered; $10 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Hawaii

People named in the notice

  • Anton C Krucky · Executive Officer, Director
  • Bradley C Perkins · Executive Officer
  • Paul C Kosnik · Executive Officer
  • Thomas C Cannon · Executive Officer, Director
  • Jeffery C Watanabe · Director
  • Michael C Ruley · Director
  • Robert C Hiam · Director
  • William C Wiesmann · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bradley Perkins, SVP, General Counsel, Secretary. Source: SEC Form D and 2 amendments, newest notice filed Jul 11, 2011. Read the notice at the SEC.

equitySEC
Mar 2010$1 MNo. 1Under $2 million

Tissue Genesis Inc.: Raise no. 1, Mar 2010

Investors in this round

3 investors had bought by the notice of Apr 22, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $9 M offered; $8 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 46
Meant to last
more than a year
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Hawaii

People named in the notice

  • Robert Hiam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bradley Perkins, Secretary. Source: SEC Form D, newest notice filed Apr 22, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tissue Genesis Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2012).

    SEC Form D · Jan 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2012

That is all the official record says: Tissue Genesis Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tissue Genesis Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 53 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tissue Genesis Inc.
NameRoleNamed in
Anton C KruckyExecutive officerJan 2012
Paul C KosnikExecutive officerJan 2012
Thomas C CannonExecutive officerJan 2012
Bradley C PerkinsExecutive officerJul 2011
Anton C. KruckyExecutive officerJan 2011
Bradley C. PerkinsExecutive officerJan 2011
Paul C. KosnikExecutive officerJan 2011
Thomas C. CannonExecutive officerJan 2011
Anton C KruckyDirectorJan 2012
Jeffrey C WatanabeDirectorJan 2012
Michael C RuleyDirectorJan 2012
Robert C HiamDirectorJan 2012
Thomas C CannonDirectorJan 2012
Jeffery C WatanabeDirectorJul 2011
William C WiesmannDirectorJul 2011
Anton C. KruckyDirectorJan 2011
Jeffery C. WatanabeDirectorJan 2011
Michael C. RuleyDirectorJan 2011
Robert C. HiamDirectorJan 2011
Thomas C. CannonDirectorJan 2011
William C. WiesmannDirectorJan 2011
Bradley C. PerkinsDirectorJul 2010
Jeff C. WatanabeDirectorJul 2010
Robert HiamDirectorApr 2010